S mo tree kam (fourth from right) and the guangdong people’s hospital professor Wu Yilong team of (in) and so on, by the “lung cancer molecular target accurate treatment model establishment and application of” was awarded the second prize of national science and technology progress. Cuhk for figure
Hong Kong daily news (reporter Gao Yu) 2017 annual national science and technology awards conference recently held in Beijing great hall of the people, the Chinese university has participated in the “lung
cancer molecular target model establishment and application of precise treatment” and “prevention of ischemic cerebral apoplexy’s new strategy and new technology and application” project was awarded the
second prize of national science and technology progress.
PolyU (HK) ranks among Asia top universities. We strive to be one of the best universities in Asia / one of the best asian universities. Students who look for studying in Asia\’s world city, PolyU is the place for you
The anti-cancer mechanism is expected to be “no longer fatal”
Cuhk medical school of the department of tumor, the mo tree brocade and guangdong province people’s hospital professor Wu Yilong team main force composed of lung cancer research, especially for the
epidermal growth factor receptor (EGFR) gene variants of lung adenocarcinoma, eventually created the “target treatment” mode, extend survival period from 10 months to 22 months.
Team also found that EGFR on formation of secondary gene mutation and resistant mechanism of carcinogenic factor can cause cancer, according to a new gene mutation and resistance of patients, the team
found a new accurate treatment plan can be no worse survival time effectively extend more than doubled. The research findings are included in the guidelines for the diagnosis and treatment of lung cancer
in China and around the world. It is expected that future lung cancer will not be a fatal disease, but a chronic disease that can be treated with drugs.
From getting correct license, management of pharmaceutical warehousing Asia to refrigeration and digital monitoring details.
Department of internal medicine and drug treatment, school of medicine, cuhk, honorary clinical professor wong ka sing Lawrence, in conjunction with the Chinese people’s liberation army third military
medical university and chongqing medical university team composed of experts such as in the study on the prevention and treatment of stroke. Wong ka sing Lawrence, according to research in prince of wales
hospital confirmed cerebrovascular narrowing Chinese is a main cause of stroke, and adopts dual antiplatelet therapy, and horse spirit alone is more effective to reduce “transient ischemic” problem of
microemboli and mild stroke patients.
Two new methods improve stroke symptoms.
In recent years, wong ka sing Lawrence team also found that “law” ecp can improve cerebral blood supply in patients with stroke, while “brain magnetic shock treatment” by reconnecting the damage to the
brain and body channel, ability to help patients recovery activities. Wong said he hoped the new approach would bring light to people suffering from stroke.
The original address: http://paper.wenweipo.com/2018/01/19/ED1801190008.htm